Page 31 - Pivotal Program Progress News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pivotal program progress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pivotal Program Progress Today - Breaking & Trending Today

Bellerophon Therapeutics, Inc. Announces Top-Line Data from Phase 3 REBUILD Clinical Trial of INOpulse® for Treatment of Fibrotic Interstitial Lung Disease

Bellerophon Therapeutics, Inc. announced top-line results from its pivotal Phase 3 REBUILD clinical trial evaluating the safety and efficacy of INOpulse® for the treatment of fibrotic Interstitial. | June 6, 2023 ....

Bellerophon Therapeutics Inc , Bellerophon Therapeutics , Interstitial Lung Disease , Overall Activity , Walk Distance , Respiratory Questionnaire , Clinical Worsening , Clinical Deterioration , Clinical Improvement , Nc Stock Exchange , Press Release , Ibrotic Blph Us0787713009 ,

Dear shareholders,

We have been managing Visiomed Group since April 2022. The last 13 months were a pivotal time where the Group has reached financial stability and sustainable. | June 6, 2023 ....

United Arab Emirates , Saudi Arabia , Guillaume Bremond , Thomas Picquette , Visiomed Group , Smart Salem , Dubai Knowledge Park , Joint Venture , Middle East , General Meeting , Chief Executive Officer , Visiomed Group Sa Stock Exchange , Press Release , Nd Alvmg Fr0013481835 ,

Welcome To IANS Live - ENTERTAINMENT - Sushmita Sen wraps up Season 3 of 'Aarya' with a dance and a hug

The actress took to her social media profile and dropped a video from the sets. She wrote: ....

Vinod Rawat , Sushmita Sen , Ram Madhvani , Sikandar Kher , Gauri Sawant , Manish Chaudhari , Namit Das ,

Sutro Biopharma, Inc.: Sutro Biopharma Announces Oral Presentation at ASCO 2023 Featuring Data for Luveltamab Tazevibulin from the Phase 1 Dose-Expansion Study in Ovarian Cancer and the Initiation of the Phase 2/3 Pivotal Study REFRaME-O1

- Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab tazevibulin, or luvelta, in ovarian cancer, demonstrating ....

United States , Israel General , Comunidad Autonoma De Cataluna , Sutro Biopharma , Anne Borgman , Luveltamab Tazevibulin , Bristol Myers Squibb , Amy Bonanno , Astellas Pharma , Anniej Chang , American Society Of Clinical Oncology , Exchange Commission , Hebron University Hospital , Solebury Strategic Communications , Sutro Biopharma Inc , Hebron Institute Of Oncology , Clinical Oncology , Annual Meeting , Principal Investigator , Ana Oaknin , Gynecological Tumor Unit , Attending Physician , Principal Clinical Investigator , Gynecological Malignancies Group , Hebron Institute , Tumor Proportion Score ,

Jazz Pharmaceuticals plc: Jazz Pharmaceuticals and Zymeworks Present Positive Pivotal Phase 2b Trial Data at ASCO 2023 Evaluating Zanidatamab in HER2-Amplified Biliary Tract Cancers

Results presented today at ASCO 2023 and concurrently published in The Lancet Oncology demonstrate meaningful clinical benefit including antitumor activity, confirmed objective response rate ....

United States , British Columbia , Zymework Azymetric , Diana Papove , Jack Spinks , Andrean Flynn , Rob Iannone , Kristin Bhavnani , University Of Texas Md Anderson Cancer Center , Prnewswire Jazz Pharmaceuticals , Zymeworks Inc , Exchange Commission , European Medicines Agency , American Society Of Clinical Oncology , Corporate Communications , Securities Exchange , Department Of Investigational Cancer Therapeutics , Beigene Ltd , Jazz Pharmaceuticals Ireland Limited , Department Of Gastrointestinal Medical Oncology , Commission File No , Jazz Pharmaceuticals , Drug Administration , Lancet Oncology , American Society , Clinical Oncology ,